Pigmentation is one of the most common reasons people seek skincare advice in India. But treating pigmentation in Indian skin is not just about fading a dark mark. The treatment also has to work in a country with high UV exposure, increasing heat, humidity, and a population where sensitive skin is common.

Here are 7 reasons why tranexamic acid (TXA) has become one of the most important pigmentation molecules in modern skincare:

1. Most Indian skin is reactive.

A nationally representative survey of more than 3,000 Indians found that 27.9% of men and 36.7% of women describe their skin as sensitive or very sensitive.

The important finding was this: people with sensitive skin reacted to cosmetics almost twice as often as everyone else (14.7% vs 5.5%).

When almost one in three people have sensitive skin, a pigmentation ingredient cannot just be effective. It also has to be gentle enough to be used consistently.

2. TXA is gentler by design.

Pure L-ascorbic acid (vitamin C) works best at a low, acidic pH. That acidity is often what causes stinging and irritation, especially in sensitive skin.

Tranexamic acid works at a much milder pH and does not exfoliate the skin.

In a large melasma meta analysis, TXA had the lowest irritation rate of all the major pigmentation ingredients studied: 0.8%, compared with 18.3% for hydroquinone, 18.7% for azelaic acid, 42.2% for cysteamine and 50.9% for combination hydroquinone creams.

3. TXA holds up better in Indian weather.

Pure vitamin C is not a particularly stable molecule. Heat, humidity and exposure to air gradually reduce its potency.

Tranexamic acid is far more stable, which matters in a country where high heat and humidity are part of everyday life for much of the year.

4. As India gets hotter, pigmentation is increasingly linked to redness.

Between 2015 and 2020, the number of Indian states affected by heatwaves increased from 9 to 23. Average heatwave days rose from 7.4 to 32.2.

This matters because melasma is not just excess pigment. Studies have shown increased blood vessel density and elevated VEGF within affected skin.

Tranexamic acid helps address this vascular component by reducing VEGF and endothelin-1 signalling.

5. TXA helps interrupt the pigmentation process earlier.

Sun exposure and heat trigger a chain of events inside the skin that eventually leads to excess pigment production.

Tranexamic acid helps interrupt some of these signals before they result in visible pigmentation.

In a country with high UV exposure and increasing heat stress, addressing these early signals can be particularly valuable.

6. The evidence base is remarkably strong.

A Harvard meta analysis covering 45 studies and 2,359 patients found that tranexamic acid was the most studied non hydroquinone ingredient for melasma, with 11 topical studies.

Standalone topical vitamin C did not meet the minimum number of studies needed to be assessed independently as a melasma treatment.

Importantly, much of the TXA data comes from Indian, Iranian and Egyptian populations, making it highly relevant to skin of colour.

7. TXA delivers meaningful results without demanding too much from the skin.

In the same analysis, TXA achieved results comparable to hydroquinone, the long standing benchmark for pigmentation treatment.

The significance is not that TXA dramatically outperforms hydroquinone. The significance is that it approaches gold standard results while maintaining one of the lowest irritation rates reported among pigmentation ingredients.

For Indian skin, where pigmentation and sensitivity often coexist, that is a compelling combination - a new way to think about pigmentation.

One of the more interesting developments in pigmentation science is the growing recognition that many pigment disorders are not purely pigment disorders. Melasma, for example, often contains a vascular component, with increased blood vessel density and elevated VEGF within affected skin.

As heat exposure becomes a larger part of the modern exposome, the relationship between redness and pigmentation becomes increasingly relevant.

This may partly explain why ingredients such as tranexamic acid continue to attract attention. They are not only acting on pigment pathways, but also on some of the inflammatory and vascular signals that sit upstream of pigmentation.

In other words, the future of pigmentation management may involve paying closer attention to redness. That understanding has shaped our thinking behind Re(d)covery Serum, where pigmentation, redness and barrier health are considered together rather than as separate concerns.

Because sometimes the question is not just, "How do we fade a mark?" It is, "Why did the skin create it in the first place?"

You may also like to explore: